Critical Path Institute launches new neonatal consortium

The Tucson-based Critical Path Institute formed its ninth consortium, the International Neonatal Consortium (INC), which aims to accelerate the development of safe, effective therapies for newborns.

INC is the latest in a series of successful developments for C-Path, which include the celebration of its 10th anniversary and the opening of a new office in London.

The C-Path-appointed Executive Director of the new consortium is Dr. Alan Bedrick, who will continue to serve as Chief of Neonatology and Developmental Biology at the University of Arizona College of Medicine–Tucson.